20 November 2017
News and Views
Links and Services
The most recent issue of the Journal of Hepatology examines the impact of peginterferon and ribavirin therapy on hepatocellular carcinoma, and survival in hepatitis C patients with advanced fibrosis.
Hepatocellular carcinoma currently represents the major cause of liver-related death in patients
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors